Every year 14 million mothers develop severe bleeding after childbirth or postpartum haemorrhage (PPH) as it is also known, and about 2% of them will die, with an average of 2-4 hours from the start of bleeding to death. The WOMAN trial aims to provide the research based information, as to whether an old drug, tranexamic acid (TXA), can improve the outcomes for women who develop this life-threatening condition, and ultimately save lives. TXA is a drug developed in the 1950's, which is commonly used in other bleeding conditions. It works by maintaining the clots which prevent further bleeding.

More on This

Simple Drug May Save Thousands of Bleeding Mothers

• We Have the Right Medicine - Now We Need the Commitment
• The Trial Explained
• Commonly Used Drug May Be Key to Stopping Thousands of Mothers Dying
• Toyin Saraki Says Why Drug Trial for Women is Close to Her Heart

'My Wife, Child Died Because I Couldn't Afford Antenatal Care'

• Why the Death of a Woman after Giving Birth to Quadruplets Should Change Healthcare
• My Wife, Our Quadruplets Dead After I Denied Them Antenatal Care - Bereaved Man